About this trial
The treatment of persistent lumbar radicular pain (LRP) using CT-guided epidural steroid injection (ESI) is widely used and associated with rare but serious complications. Platelet-rich plasma (PRP), which has recently been shown to promote healing and the anti-inflammatory process by delivering growth factors and cytokines, could be an alternative and potentially safer option. A previous study showed that PRP was as effective as ESI in treating this condition, without major complications.
This study aims to compare these two treatments over the long term (2 years).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of unilateral resistant LRP associated with a herniated disc on MRI images. (Diagnosis of resistance after 6 weeks of appropriate medical treatment).
Disqualifiers
Patients with infections,
Patients who have had previous percutaneous corticosteroid injections,
Patients undergoing systemic corticosteroid treatment,
Patients with immune deficiencies,
Trial design
Parallel
Treatments tested in this trial
Epidural Steroid Injection
Procedure/SurgeryIntervention consists of interlaminar CT guided epidural steroid injection
Epidural platelet-rich plasma injection
Procedure/SurgeryIntervention consists of interlaminar CT guided epidural platelet-rich plasma injection after recovery of plasma by blood sampling and centrifugation
Treatment groups
Trial outcomes
Primary outcomes
Functional ability
Oswestry Disability Questionnaire ranging from 0 to 100%
Secondary outcomes
Pain evaluation
Numerical pain rating scale (NRS): intensity of combined pain in the legs and back ranging from 0 to 10
Sponsors and contacts
Click on the lead sponsor to view all of their trials.